iBiotech LTD has joined forces with iNatural LTD, a new start-up company also based in Wolverhampton, recently celebrated for its innovation in the health sector. iNatural LTD, founded by Dr. Abhishek Gupta, secured second place in the prestigious Santander X finals held in Milton Keynes at the Unity recently; earning a £10,000 funding and support. Attendees of the event included entrepreneur Sam Jones (founder of Gener8), Dame Jessica Ennis-Hill and former United player and current businessman Gary Neville.
Dr. Gupta, also a tenant at the University of Wolverhampton's SPEED business incubator, was recognised for his visionary work in the field of medical technology, which has garnered attention for its innovative potential. The project also has many sustainability aspects, hence iBiotech's interest.
The successful completion of the Santander X competition marks a major milestone for iNatural, whose approach focuses on integrating natural compounds with modern medical practices to enhance therapeutic solutions. As part of this collaboration, iBiotech LTD, will support iNatural by sharing valuable network contacts, resources, and expertise. iBiotech, based in Wolverhampton, has established itself as a forward-thinking company that combines advanced research with sustainable solutions, making it an ideal partner for iNatural in its next phase of growth. The synergy between iBiotech and iNatural promises to yield exciting developments in medical technology, with both companies focused on improving healthcare outcomes.
Dr. Gupta expressed his excitement about the partnership, saying, "This collaboration with iBiotech will be a game-changer. Their experience and industry insights, combined with our ground-breaking ideas and success with Innovate-UK, Sky's the Limit, Enterprise Nation and other programmes, will help accelerate the development of iNatural LTD."
For now, the collaboration signals a bright future for both companies, as they work together to shape the future, with new technology combined with natural science.
